Parry Romberg's disease with intractable partial epilepsy

Neurology India

Volumn 55, Issue 2, 2007, Pages 160-162

  Haldar, Amit ^a,b   Mukherjee, Arabinda ^a  

^a VIVEKANANDA INSTITUTE OF MEDICAL SCIENCES   (India)

^b CD 296 ^*  (India)

Author keywords

Autoimmune; Parry Romberg's syndrome; Partial epilepsy; Steroid responsiveness

Indexed keywords

CARBAMAZEPINE; CLOBAZAM; CORTICOSTEROID; LAMOTRIGINE; PHENOBARBITAL; PREDNISOLONE; VALPROIC ACID;

ADOLESCENT; ANAMNESIS; ARTICLE; AUTOIMMUNE DISEASE; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CORTICOSTEROID THERAPY; DRUG DOSE REDUCTION; ELECTROENCEPHALOGRAPHY; FEMALE; FOCAL EPILEPSY; HEMIFACIAL ATROPHY; HUMAN; INTRACTABLE EPILEPSY; LYMPHOCYTE COUNT; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; PLASTIC SURGERY; SYSTEMIC THERAPY; TONIC CLONIC SEIZURE; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 34250363559     PISSN: 00283886     EISSN: None     Source Type: Journal    
DOI: 10.4103/0028-3886.32791     Document Type: Article

References (14)

1. Mendonca J, Viana SL, Freitas F, Lima G. Late-onset progressive facial hemiatrophy (Parry-Romberg syndrome). J Postgrad Med 2005;51:135-6.
2. Asher SW, Berg BO. Progressive hemifacial atrophy: Report of three cases, including one observed over 43 years, and computed tomographic findings. Arch Neurol 1982;39:44-6.
3. Stone J. Parry-Romberg syndrome: A global survey of 205 patients using the Internet. Neurology 2003;61:674-6.
4. Dupont S, Catala M, Hasboun D, Semah F, Baulac M. Progressive facial hemiatrophy and epilepsy: A common underlying dysgenetic mechanism. Neurology 1997;48:1013-8.
5. Wartenberg R. Progressive facial hemiatrophy. Arch Neurol Psychiatry 1945;54:75-96.
6. Gambichler T, Kreuter A, Hoffmann K, Bechara FG, Altmeyer P, Jansen T. Bilateral linear scleroderma "en coup de sabre" associated with facial atrophy and neurological complications. BMC Dermatol 2001;1:9.
7. Blaszczyk M, Janninger CK, Jablonska S. Childhood scleroderma and its pecularities. Cutis 1996;58:141-52.
8. Garcia-de-la Torre I, Castello-Sendra J, Esgleyes-Ribot T, Martinez-Bonilla G, Guerrerosantos J, Fritzler MJ. Autoantibodies in Parry Romberg syndrome: A serologic study of14 patients. J Rheumatol 1995;22:73-7.
9. Kleiner-Baumgarten A, Sukenik S, Howitz J. Linear scleroderma, hemiatrophy and systemic lupus erythrematosus. J Rheumatol 1989;16:1141-3.
10. Littman B. Linear scleroderma: A response to neurological injury? Report and literature review. J Rheumatol 1989;16:1135-40.
11. Korkmaz C, Adapinar B, Uysal S. Beneficial effect of immunosuppressive drugs on Parry-Romberg syndrome: A case report and review of the literature. South Med J 2005;98:940-2.
12. Straube A, Padovan CS, Seelos K. Parry-Romberg syndrome and Rasmussen syndrome: Only an incidental similarity? Nervenarzt 2001;72:641-6.
13. Shah R, Juhász C, Kupsky WJ, Asano E, Sood S, Fain D, et al. Rasmussen encephalitis associated with Parry-Romberg syndrome. Neurology 2003;61:395-7.
14. Pupillo G, Andermann F, Dubeau F. Linear Scleroderma and intractable epilepsy: Neuropathologic evidence for a chronic inflammatory process. Ann Neurol 1996;39:277-8.